The Latin America, Middle East and Africa Adhesion Barrier Market should witness market growth of 9.0% CAGR during the forecast period (2023-2030).
Adhesions can result in severe complications such as bowel obstructions, infertility, and complications during subsequent surgeries. By preventing adhesions from forming in the first place, adhesion barriers aid in reducing these risks.
When adhesions are prevented, patients frequently recover from surgery more quickly. It includes a quicker return to normal activities and decreased postoperative hospital stays. Sometimes, adhesions require additional surgeries to rectify complications. Adhesion barriers can help reduce the need for subsequent procedures, saving patients the physical and financial burden of having several surgeries.
The Middle East has prevalence rates of 23.5-62.1 for overweight and 14.5-40.6 for obesity. According to the National Library of Medicine, Israel, Kuwait, and Syria had the greatest rates of overweight and obese people. The increase in the prevalence of non-communicable diseases, such as obesity, can be attributed to changes in lifestyle over the past few decades, such as the adoption of Arabic diets (high-calorie, fattening meals, such as fast food), increased alcohol consumption, and decreased physical activity. As a result, a higher prevalence of orthopedic problems may be caused by the rising incidence of obesity and overweight in this region. As a result, the market's growth prospects will improve throughout the forecast period.
The Brazil market dominated the LAMEA Adhesion Barrier Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $22 million by 2030. The Argentina market is showcasing a CAGR of 9.6% during (2023-2030). Additionally, The UAE market would register a CAGR of 8.7% during (2023-2030).
Based on Application Area, the market is segmented into General/Abdominal Surgeries, Orthopedic Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Urological Surgeries, Neurological Surgeries, Reconstructive Surgeries, and Others. Based on Formulation, the market is segmented into Film Formulations, Gel Formulations, and Liquid Formulations. Based on Product, the market is segmented into Synthetic Products (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, and Others), and Natural Products. Based on End-user, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Sanofi S.A., Becton Dickinson and Company, Baxter International, Inc.(Hill-Rom Holdings, Inc.), Johnson & Johnson, Anika Therapeutic, Inc., FzioMed, Inc., MAST Biosurgery USA, Inc.(MAST Biosurgery AG), Innocoll Biotherapeutics N.A. Inc., Luna Innovations, Incorporated and Integra LifeSciences Holdings Corporation.
Adhesions can result in severe complications such as bowel obstructions, infertility, and complications during subsequent surgeries. By preventing adhesions from forming in the first place, adhesion barriers aid in reducing these risks.
When adhesions are prevented, patients frequently recover from surgery more quickly. It includes a quicker return to normal activities and decreased postoperative hospital stays. Sometimes, adhesions require additional surgeries to rectify complications. Adhesion barriers can help reduce the need for subsequent procedures, saving patients the physical and financial burden of having several surgeries.
The Middle East has prevalence rates of 23.5-62.1 for overweight and 14.5-40.6 for obesity. According to the National Library of Medicine, Israel, Kuwait, and Syria had the greatest rates of overweight and obese people. The increase in the prevalence of non-communicable diseases, such as obesity, can be attributed to changes in lifestyle over the past few decades, such as the adoption of Arabic diets (high-calorie, fattening meals, such as fast food), increased alcohol consumption, and decreased physical activity. As a result, a higher prevalence of orthopedic problems may be caused by the rising incidence of obesity and overweight in this region. As a result, the market's growth prospects will improve throughout the forecast period.
The Brazil market dominated the LAMEA Adhesion Barrier Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $22 million by 2030. The Argentina market is showcasing a CAGR of 9.6% during (2023-2030). Additionally, The UAE market would register a CAGR of 8.7% during (2023-2030).
Based on Application Area, the market is segmented into General/Abdominal Surgeries, Orthopedic Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Urological Surgeries, Neurological Surgeries, Reconstructive Surgeries, and Others. Based on Formulation, the market is segmented into Film Formulations, Gel Formulations, and Liquid Formulations. Based on Product, the market is segmented into Synthetic Products (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, and Others), and Natural Products. Based on End-user, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Sanofi S.A., Becton Dickinson and Company, Baxter International, Inc.(Hill-Rom Holdings, Inc.), Johnson & Johnson, Anika Therapeutic, Inc., FzioMed, Inc., MAST Biosurgery USA, Inc.(MAST Biosurgery AG), Innocoll Biotherapeutics N.A. Inc., Luna Innovations, Incorporated and Integra LifeSciences Holdings Corporation.
Scope of the Study
By Application Area
- General/Abdominal Surgeries
- Orthopedic Surgeries
- Gynecological Surgeries
- Cardiovascular Surgeries
- Urological Surgeries
- Neurological Surgeries
- Reconstructive Surgeries
- Others
By Formulation
- Film Formulations
- Gel Formulations
- Liquid Formulations
By Product
- Synthetic Products
- Hyaluronic Acid
- Regenerated Cellulose
- Polyethylene Glycol
- Others
- Natural Products
By End-user
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Sanofi S.A.
- Becton Dickinson and Company
- Baxter International, Inc. (Hill-Rom Holdings, Inc.)
- Johnson & Johnson
- Anika Therapeutic, Inc.
- FzioMed, Inc.
- MAST Biosurgery USA, Inc. (MAST Biosurgery AG)
- Innocoll Biotherapeutics N.A. Inc.
- Luna Innovations, Incorporated
- Integra LifeSciences Holdings Corporation
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Adhesion Barrier Market by Application Area
Chapter 5. LAMEA Adhesion Barrier Market by Formulation
Chapter 6. LAMEA Adhesion Barrier Market by Product
Chapter 7. LAMEA Adhesion Barrier Market by End User
Chapter 8. LAMEA Adhesion Barrier Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Sanofi S.A.
- Becton Dickinson and Company
- Baxter International, Inc.(Hill-Rom Holdings, Inc.)
- Johnson & Johnson
- Anika Therapeutic, Inc.
- FzioMed, Inc.
- MAST Biosurgery USA, Inc.(MAST Biosurgery AG)
- Innocoll Biotherapeutics N.A. Inc.
- Luna Innovations, Incorporated
- Integra LifeSciences Holdings Corporation
Methodology
LOADING...
